KARAKTERISTIK PASIEN TUBERCULOSIS PARU DEWASA DI PUSKESMAS LUBUK BUAYA KOTA PADANG TAHUN 2024

Laila Kurnia Raisa; Rosmaini Rosmaini; Zukhri Zainun

doi:10.59003/nhj.v5i8.1843

Authors

Laila Kurnia Raisa Universitas Baiturrahmah
Rosmaini Rosmaini Universitas Baiturrahmah
Zukhri Zainun Universitas Baiturrahmah

DOI:

https://doi.org/10.59003/nhj.v5i8.1843

Keywords:

characteristics, pulmonary tuberculosis, adult patients

Abstract

Pulmonary tuberculosis, a chronic, infectious disease affecting the lung parenchyma, is caused by the bacterium Mycobacterium tuberculosis and spreads from person to person through the air. Tuberculosis is among the top 10 causes of death worldwide, increasing annually. To determine the characteristics of adult pulmonary tuberculosis patients at the Lubuk Buaya Community Health Center in Padang City in 2024, the study was conducted from February to July 2025. This descriptive, observational study involved 80 samples from all pulmonary tuberculosis patients, using a total sampling technique. The characteristics of adult pulmonary tuberculosis patients at the Lubuk Buaya Community Health Center in Padang City in 2024 were mostly based on age, 24 people (30.00%), male gender 57 people (71.25%), no history of diabetes mellitus 55 people (68.8%), negative history of HIV 79 people (88.7%), type of diagnosis was clinical bacteriological 73 people (91.3%), category 1 OAT therapy 80 people (100.0%) and the final outcome of treatment was mostly cured 78 people (97.5%). The characteristics of adult pulmonary tuberculosis patients at the Lubuk Buaya Community Health Center in Padang City in 2024 were mostly aged 18-25 years, male, type of diagnosis bacteriological, no history of diabetes, HIV negative status, category 1 OAT therapy and the final outcome of treatment was cured.

Downloads

Download data is not yet available.

References

Perhimpunan Dokter Paru Indonesia, “Tuberkulosis Pedoman Diagnosis Dan Penatalaksanaan Di Indonesia.,” vol. 001, 2021.

WHO, Global Report Tuberkulosis Tahun 2024. 2024. [Online]. Available: https://iris.who.int/bitstream/handle/10665/379339/9789240101531eng.pdf%0A?sequence=1

H. R. Sutriyawan A, Nofianti N, “Faktor yang Berhubungan dengan Kejadian Tuberkulosis Paru.,” J Ilmu Kesehat., vol. 4, no. 1, pp. 98–105, 2022, doi: 10.36590/jika.v4i1.228.

Kemenkes RI., “Kenali Bahaya TB Paru, dan Cara Penanggulangannya,” Direktorat Jenderal Kesehat. Lanjutan., 2024, [Online]. Available: https://yankes.kemkes.g

Badan Pusat Statistik Sumatera Barat, “Provinsi Sumatera Barat Dalam Angka Tahun 2023.,” 2023, [Online]. Available: https://web-api.bps.go.id

Dinas Kehatan Kota Padang, Laporan Dinas Kesehatan Kota Padang tahun 2024, 2025th ed. 2024.

A. L. Association, “Occupational Lung Diseases,” Am. Lung Assoc., 2025.

Kementrian Kesehatan RI., Pedoman Nasional Pelayanan Kedokteran. (Jakarta, ed.).; 2020., Ed. Jakarta, 2020.

B. B. Haryani L, Ramadhani NR, Meirawan RF, “Gambaran Faktor Risiko Pasien HIV dengan Tuberkulosis di RSUD Kota Bogor.,” J Epidemiol Kesehat Indones., vol. 7, no. 2, p. 105, 2023, doi: 10.7454/epidkes.v7i2.6.

S. L. Kahar F, Purlinda DE, “Profil Diabetes Mellitus Pada Penderita Tuberculosis 2022;5:.,” Pros Semin Nas UNIMUS., vol. 5, pp. 1086–1095, 2022.

S. K. Lemeshow, S., Hosmer, D. W., Klar, J., & Lwanga, Adequacy of Sample Size in Health Studies. Chichester, UK, 1990.

Sugiono, Penelitian Kuantitatif Kualitatif R & D. Bandung: Alfabeta., 2015.

K. J. Snow, L. J. Nelson, C. Sismanidis, S. M. Sawyer, and S. M. Graham, “Incidence and prevalence of bacteriologically confirmed pulmonary tuberculosis among adolescents and young adults: a systematic review.,” Epidemiol. Infect., 2018.

D. Anisa, Y. N., Rahayu, S., & Putri, “Distribusi kasus TB paru berdasarkan usia produktif di Semarang.,” J. Kesehat. Masy. Indones., vol. 15, no. 1, pp. 23–31, 2020, doi: 10.1234/jkmi.v15i1.2020.

M. A. Dinda Mustika Alamanda, Siti Maulidya Sari, “Gambaran Epidemiologis Tuberkulosis Paru Periode 2020–2021 di Puskesmas Kecamatan Cempaka Putih,” J. Indones. Sos. Sains., vol. 4, no. 2, pp. 113–120, 2023, doi: https://doi.org/10.59141/jiss.v4i02.773.

R. I. B. Nurhalisah and Suarnianti, “Analisis Disparitas Prevalensi Tuberculosis Paru Di Tinjau Dari Faktor Sosiodemografi,” JIMPK J. Ilm. Mhs. Penelit. Keperawatan, vol. 3, no. 3, pp. 112–120, 2023.

I. D. Maulida, D. H., Dewi, I. M. W., Santoso, P., Cahyadi, A. I., Kusumawati, M., & Kulsum, “Prevalensi dan Karakteristik Pasien Tuberkulosis Paru Resisten Obat (TB-RO) dengan Diabetes Melitus Tipe 2 di Klinik TB-RO Rumah Sakit Umum Pusat Dr. Hasan Sadikin, Bandung,” J Penyakit Dalam Indones., vol. 11, no. 1, 2024, doi: https://doi.org/10.7454/jpdi.v11i2.1550.

A. Alamanda, D. M., Sari, R. P., & Hidayat, “Gambaran epidemiologis tuberkulosis paru periode 2020–2021 di Puskesmas Kecamatan Cempaka Putih. 4(2),” J. Indones. Sos. Sains, vol. 4, no. 2, pp. 112–120, 2023, [Online]. Available: https://www.researchgate.net/publication/369125762

M. Panayiotou, J. C. Badcock, M. H. Lim, M. J. Banissy, and P. Qualter, “Measuring Loneliness in Different Age Groups: The Measurement Invariance of the UCLA Loneliness Scale,” Assessment, vol. 30, no. 5, pp. 1688–1715, 2023, doi: DOI: 10.1177/10731911221119533.

W. Wahyudi, A. B. Sembiring, A. Z. Salsabilla, and S. Azizah Husnan, Najwa Tengku, Nurazizah Dawamah, Putri Cantika, “Faktor Risiko Tuberkulosis Paru Pada Remaja di Indonesia: Studi Literatur,” J. Kesehat. Jompa, vol. 4, no. 1, pp. 393–401, 2025, doi: 10.57218/jkj.Vol4.Iss1.1531.

I. M. Susilawaty A, Basri S, Haerana BT, Ane R La, Mappau Z, “The Risk Factors Contributing to The Occurrence of Pulmonary Tuberculosis in The Small Island of South Sulawesi, Indonesia,” Public Heal Indones., vol. 10, no. 4, pp. 104–116, 2024, doi: 10.36685/PHI.V10I4.876.

R. S. Nafsi, A., “Analisis Spasial Tuberkulosis Paru Ditinjau dari Faktor Demografi dan Tingkat Kesejahteraan Keluarga (Studi Kasus di Wilayah Kerja Puskesmas Bandarharjo Kota Semarang,” J. Penelit. dan Pengemb. Kesehat. Masy. Indones., vol. 1, no. 1, 2020, doi: https://doi.org/10.15294/jppkmi.v1i1.41419.

F. Saraswati, Z. R. Murfat, E. P. Wiriansya, and M. N. R. Akib, “Karakteristik Penderita Tuberkulosis Paru Yang Relaps Di RS Ibnu Sina Makassar,” Fakumi Med. J. J. Mhs. Kedokt., vol. 2, no. 5, pp. 319-328., 2022, doi: 10.33096/fmj.v2i5.8.

A. A. Saefina ID, “Gambaran Keberhasilan Pengobatan Tuberkulosis Pasien Sensitif Obat ( SO ) di Puskesmas Pondok Kacang Timur Tahun 2020-2023.,” J. Ilm. Indones., vol. 10, no. 6, pp. 5796–5806, 2025, doi: 10.36418/syntax-literate.v10i6.60481.

M. S. Khasanah U, Junadi P, “Gambaran Keberhasilan Pengobatan (Treatment Success Rate) Tuberkulosis Paru di Puskesmas Jatisampurna, Bekasi.,” Media Publ Promosi Kesehat Indones., vol. 7, no. 1, pp. 210–216, 2024, doi: 10.56338/mppki.v7i1.4379.

W. Wang et al., “Prevalence and clinical profile of comorbidity among newly diagnosed pulmonary tuberculosis patients: a multi-center observational study in eastern China.,” Front Med, 2025, doi: ER.

N. S. Happyanto MR, Ivone J, “An Overview of RiskFactors and Comorbidities Patients of Tuberculosis at Sukatani Public Health Center Purwakarta Regency Period 2020-2023,” J Med Heal, vol. 6, no. 2, pp. 22–30, 2024, doi: 10.28932/jmh.v6i2.8232.

T. Rebecca, D. Suadiatmika, and N. Margiani, “Karakteristik Gambaran Tuberkulosis (TB) Paru pada Foto Toraks Pasien Human Immunodeficiency Virus (HIV) Tahun 2017-2021 di RSUP Sanglah, Bali, Indonesia.,” Intisari Sains Medis., vol. 12, no. 3, pp. 934–938, 2021, doi: 10.15562/ism.v12i3.1194.

S. M. Anam MS, Syaputri H, Dadiyanto DW, “Faktor Risiko Tuberkulosis Paru Terkonfirmasi Bakteriologis.,” Sari Pediatr, vol. 19, no. 6, p. 311, 2018, doi: 10.14238/sp19.6.2018.311-5.

F. R. Kasni, Hanafi LOA, “Rasionalitas Penggunaan Obat Anti Tuberkulosis Pada Pasien Tuberkulosis Paru Di Puskesmas Poasia Kota Kendari Tahun 2021,” J Pharm Mandala Waluya., vol. 3, no. 1, pp. 1–11, 2024, doi: 10.54883/jpmw.v3i1.88.

K. Akhmad ,Rokiban, “Evaluasi Penggunaan Obat Antituberkulosis (Oat) pada Pasien Tb Paru di Puskesmas Punggur Kabupaten Lampung Tengah Periode Oktober 2022 -Oktober 2023.,” J Farm IKIFA., vol. 3, no. 1, pp. 59–70, 2014.

Kemenkes RI., “Pedoman Nasional Penanggulangan Tuberkulosis.,” 2021.

W. H. Organization., Guidelines for Treatment of Drug-Susceptible Tuberculosis. Geneva: World Health Organization., 2017.

W. H. Organization., Definitions and reporting framework for tuberculosis. Geneva: World Health Organization.

M. I. Nurul Handayani, Hario Megatsari, Agung Dwi Laksono, “Performance Analysis of Pulmonary Tuberculosis Treatment in Indonesia,” Medico-legal Updat., vol. 21, no. 3, 2021.

A. P. Laycock, K. M., Enane, L. A., & Steenhoff, “Tuberculosis in Adolescents and Young Adults: Emerging Epidemiology,” PMC, 2021.

I. I. Fujiati, R. Amelia, Y. Machrina, and I. H. Effendi, “Enhancing the Role of Primary Care Private Practitioners in Addressing Gaps in TB Care: An Analysis of National TB Data from Medan,” Open Public Health J., 2025, doi: 10.2174/0118749445391827250422075357.

R. C. RI Sugiyono , AM Naysilla , NH Susanto , D Handayani , E Burhan , A Karuniawati , T Kusmiati , BH Wibisono, BS Riyanto , IGK Sajinadiyasa I Djaharuddin, BYM Sinaga , RD Dewantara , M Karyana, H Kosasih , CJ Liang , R Ridzon , AT Neal, “Treatment outcomes of pulmonary TB in adults in Indonesia,” PMC Pubmed Cent., vol. 13, no. 2, pp. 145–152, 2025, doi: 10.5588/ijtldopen.24.0482.

W. H. Organization, WHO Consolidated Guidelines on Tuberculosis: Module 4 – Treatment (Drug-Susceptible Tuberculosis Treatment). Geneva: World Health Organization., 2022.

Kemenkes RI, “Petunjuk Teknis Penatalaksanaan Tuberkulosis Resisten Obat Di Indonesia.,” Kemenkes, 2020.

Kemenkes RI, “Petunjuk Teknis Penatalaksanaan Tuberkulosis Resisten Obat Di Indonesia.,” 2020.

O. B. Kwon et al., “Nutrition Status and Comorbidities Are Important Factors Associated With Mortality During Anti-Tuberculosis Treatment,” J. Korean Med. Sci, vol. 40, no. 17, p. e73, 2025, doi: 10.3346/jkms.2025.40.e73.